| scholarly article | Q13442814 |
| P2093 | author name string | Jing Nie | |
| E Helene Sage | |||
| P2860 | cites work | Inhibition of adipogenesis by Wnt signaling | Q22254771 |
| The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors | Q24563124 | ||
| SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix | Q24679549 | ||
| Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase | Q24682825 | ||
| Cell surface heparan sulfate proteoglycans contribute to intracellular lipid accumulation in adipocytes | Q24791488 | ||
| Structural basis of sequence-specific collagen recognition by SPARC | Q27652906 | ||
| Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen | Q28251550 | ||
| The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV | Q28289732 | ||
| A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation | Q28357136 | ||
| Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation | Q28505419 | ||
| Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen | Q28505532 | ||
| APC-dependent suppression of colon carcinogenesis by PPARgamma | Q28506424 | ||
| The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice | Q28508070 | ||
| Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes | Q29618442 | ||
| SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity | Q33222107 | ||
| IFATS collection: Combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells | Q33347082 | ||
| Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes | Q33642552 | ||
| Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. | Q33688041 | ||
| Molecular regulation of adipogenesis | Q34059685 | ||
| Matricellular proteins: extracellular modulators of cell function | Q34149511 | ||
| Reversal of obesity by targeted ablation of adipose tissue | Q34319543 | ||
| Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A | Q34331369 | ||
| Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice | Q34346225 | ||
| Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. | Q34413514 | ||
| A pericellular collagenase directs the 3-dimensional development of white adipose tissue | Q34522343 | ||
| Angiogenesis modulates adipogenesis and obesity | Q34677131 | ||
| SPARC-null mice exhibit increased adiposity without significant differences in overall body weight | Q35022737 | ||
| Adipose tissue angiogenesis | Q35698318 | ||
| Regulation of E-cadherin expression and beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. | Q35725912 | ||
| De novo adipogenesis in mice at the site of injection of basement membrane and basic fibroblast growth factor | Q35788885 | ||
| Regulation of PPARgamma activity during adipogenesis | Q36042255 | ||
| SPARC is a source of copper-binding peptides that stimulate angiogenesis | Q36234286 | ||
| PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors | Q36234340 | ||
| Laminin polymerization induces a receptor-cytoskeleton network | Q36342173 | ||
| A Wnt canon orchestrating osteoblastogenesis | Q36391330 | ||
| Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. | Q37110569 | ||
| Osteopenia and decreased bone formation in osteonectin-deficient mice | Q37176145 | ||
| Adipogenesis and WNT signalling | Q37325263 | ||
| The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity. | Q38302172 | ||
| Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin | Q38408437 | ||
| Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases | Q40184809 | ||
| SPARC represses E-cadherin and induces mesenchymal transition during melanoma development | Q40248571 | ||
| Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro | Q40307786 | ||
| Changes in integrin expression during adipocyte differentiation | Q40375216 | ||
| Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. | Q40638066 | ||
| Osteonectin-Null Mutation Compromises Osteoblast Formation, Maturation, and Survival | Q40647978 | ||
| Regulation of angiogenesis by SPARC and angiostatin: implications for tumor cell biology | Q41084437 | ||
| White fat progenitor cells reside in the adipose vasculature. | Q41145314 | ||
| SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling | Q41882825 | ||
| The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin beta1 and activation of integrin-linked kinase | Q41889041 | ||
| Haemocyte-derived SPARC is required for collagen-IV-dependent stability of basal laminae in Drosophila embryos | Q42435445 | ||
| Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis | Q42574886 | ||
| Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes | Q42820082 | ||
| Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia. | Q42833163 | ||
| Regulation of fibronectin, integrin and cytoskeleton expression in differentiating adipocytes: inhibition by extracellular matrix and polylysine | Q42834581 | ||
| The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease. | Q43668487 | ||
| SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins | Q43804262 | ||
| SPARC-null mice exhibit accelerated cutaneous wound closure | Q43826818 | ||
| Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice | Q43919367 | ||
| SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength | Q44465718 | ||
| Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro | Q44914125 | ||
| Understanding adipocyte differentiation | Q46119331 | ||
| Wnt10b inhibits development of white and brown adipose tissues | Q47364038 | ||
| SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells | Q48364943 | ||
| Extracellular matrix substrata alter adipocyte yield and lipogenesis in primary cultures of stromal-vascular cells from human adipose. | Q51722962 | ||
| Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. | Q54611050 | ||
| Collagen VI deficiency affects the organization of fibronectin in the extracellular matrix of cultured fibroblasts | Q57006982 | ||
| Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives | Q75302855 | ||
| Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation | Q79872865 | ||
| Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma | Q79918319 | ||
| Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium | Q81417028 | ||
| A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks | Q81514904 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | adipogenesis | Q2824461 |
| P304 | page(s) | 247-254 | |
| P577 | publication date | 2009-10-02 | |
| P1433 | published in | Journal of Cell Communication and Signaling | Q26841964 |
| P1476 | title | SPARC functions as an inhibitor of adipogenesis | |
| P478 | volume | 3 |
| Q34547034 | Canonical wnt signaling regulates extracellular matrix expression in the trabecular meshwork |
| Q41490210 | Genetics of body fat mass and related traits in a pig population selected for leanness |
| Q50859770 | Healthy and tumoral tissue resistivity in wild-type and sparc-/- animal models. |
| Q37925022 | Matricellular proteins: new molecular targets to prevent heart failure |
| Q64898440 | MicroRNA and Human Bone Health. |
| Q36719096 | Peri-adipocyte ECM remodeling in obesity and adipose tissue fibrosis. |
| Q27305401 | Putative regulatory factors associated with intramuscular fat content |
| Q91597546 | Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC |
| Q34261684 | Retracted: SPARC Overexpression Inhibits Cell Proliferation in Neuroblastoma and Is Partly Mediated by Tumor Suppressor Protein PTEN and AKT |
| Q35233858 | Revisiting the matricellular concept |
| Q37687199 | Roles of SPARC in urothelial carcinogenesis, progression and metastasis |
| Q39521848 | SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival. |
| Q100694445 | SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic β cells |
| Q42709950 | The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling |
Search more.